- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
36 Lymphocytes Trials Near You
Power is an online platform that helps thousands of Lymphocytes patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerRuxolitinib for Large Granular Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
28 Participants Needed
Oral Azacitidine for Leukemia
Trial Details
Key Eligibility Criteria
27 Participants Needed
Trial Details
Key Eligibility Criteria
188 Participants Needed
Immunotherapy + Chemotherapy for Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
994 Participants Needed
Trial Details
Key Eligibility Criteria
422 Participants Needed
CMV-Specific CTLs for CMV Infection
Trial Details
Key Eligibility Criteria
20 Participants Needed
Cytotoxic T-Lymphocytes for Adenovirus Infections
Trial Details
Key Eligibility Criteria
20 Participants Needed
Autologous Immune Cell Therapy for Leukemia
Trial Details
Key Eligibility Criteria
70 Participants Needed
Lifileucel + Pembrolizumab for Melanoma
Trial Details
Key Eligibility Criteria
670 Participants Needed
Tabelecleucel for EBV Associated Diseases
Trial Details
Key Eligibility Criteria
190 Participants Needed
OBX-115 for Skin Cancer
Trial Details
Key Eligibility Criteria
52 Participants Needed
TIL Therapy + Pembrolizumab for Skin Cancer
Trial Details
Key Eligibility Criteria
2 Participants Needed
LYL845 for Solid Cancers
Trial Details
Key Eligibility Criteria
39 Participants Needed
Pembrolizumab Combinations for Melanoma
Trial Details
Key Eligibility Criteria
315 Participants Needed
Tabelecleucel for Post-Transplant Cancer
Trial Details
Key Eligibility Criteria
66 Participants Needed
Fianlimab + Cemiplimab vs Pembrolizumab for Melanoma
Trial Details
Key Eligibility Criteria
1564 Participants Needed
TIL Therapy for Cervical Cancer
Trial Details
Key Eligibility Criteria
189 Participants Needed
Tumor Infiltrating Lymphocyte Therapy for Cancer
Trial Details
Key Eligibility Criteria
245 Participants Needed
Autologous LN-145 for Lung Cancer
Trial Details
Key Eligibility Criteria
170 Participants Needed
ANB032 for Eczema
Trial Details
Key Eligibility Criteria
160 Participants Needed
Why Other Patients Applied
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Immunotherapy for Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
70 Participants Needed
Belimumab for Pediatric Lupus
Trial Details
Key Eligibility Criteria
93 Participants Needed
IOV-4001 for Melanoma and Lung Cancer
Trial Details
Key Eligibility Criteria
53 Participants Needed
Trial Details
Key Eligibility Criteria
950 Participants Needed
LN-144 + Pembrolizumab for Melanoma
Trial Details
Key Eligibility Criteria
12 Participants Needed
Fianlimab + Cemiplimab for Melanoma
Trial Details
Key Eligibility Criteria
1535 Participants Needed
Favezelimab + Pembrolizumab for Endometrial Cancer
Trial Details
Key Eligibility Criteria
160 Participants Needed
BNT116 + Standard Therapy for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
220 Participants Needed
PD-1 Inhibitor + Diabetes Drugs for Solid Malignant Tumors
Trial Details
Key Eligibility Criteria
72 Participants Needed
Chemotherapy + Pembrolizumab for Head and Neck Cancer
Trial Details
Key Eligibility Criteria
15 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Lymphocytes clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Lymphocytes clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lymphocytes trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Lymphocytes is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Lymphocytes medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Lymphocytes clinical trials?
Most recently, we added LN-144 + Pembrolizumab for Melanoma, Lifileucel for Endometrial Cancer and Immunotherapy for Hodgkin's Lymphoma to the Power online platform.